Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 31,159 |
| Other current assets | 109 |
| TOTAL | $31,268 |
| Non-Current Assets | |
| PPE Net | 350 |
| TOTAL | $350 |
| Total Assets | $31,603 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 1,450 |
| Accrued Expenses | 213 |
| TOTAL | $1,663 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 10,435 |
| TOTAL | $10,435 |
| Total Liabilities | $12,098 |
| Shareholders' Equity | |
| Common Shares | 4 |
| Retained earnings | -10,652 |
| Other shareholders' equity | 29,567 |
| TOTAL | $19,505 |
| Total Liabilities And Equity | $31,603 |